Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Infect Chemother ; 27(3): 439-444, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33129693

ABSTRACT

INTRODUCTION: There is an insufficient number of infectious disease (ID) physicians in Japan. Hence, we considered a strategy to implement antimicrobial stewardship under these resource-limited settings. METHODS: We compared carbapenem consumption, measured as days of therapy per 100 patient-days, between 24-month baseline and 12-month intervention periods. During the intervention period, an ID physician provided daily advises to prescribers against prolonged carbapenem use (≥14 days). Additionally, we sent all doctors a table containing the weekly point prevalence aggregate of carbapenem use of each department for 7-13 and ≥ 14 days via e-mail. RESULTS: Among the 1241 carbapenem courses during the intervention period, the ID physician provided a total of 96 instances of feedback regarding carbapenem use for ≥14 days, with an acceptance rate of 76%. After the initiation of the intervention, the trend in monthly carbapenem consumption changed (coefficient: -0.62; 95% CI: -1.15 to -0.087, p = 0.024), and its consumption decreased (coefficient: -0.098; 95% CI: -0.16 to -0.039, p = 0.002) without an increase in the consumption of broad-spectrum antimicrobials or in-hospital mortality. Interestingly, the monthly number of carbapenem courses, but not the duration of carbapenem use, significantly decreased (coefficient: -3.02; 95% CI: -4.63 to -1.42, p = 0.001). The carbapenem-related annual estimated savings after the intervention was $83,745, with a 22% cost reduction. CONCLUSIONS: Our ID physician-led daily intervention with weekly feedback regarding long-term carbapenem use was effective in reducing antimicrobial consumption. Such feedback may be useful in changing the prescribing behavior and promoting appropriate antimicrobial usage even in resource-limited settings.


Subject(s)
Communicable Diseases , Physicians , Anti-Bacterial Agents/therapeutic use , Carbapenems/therapeutic use , Communicable Diseases/drug therapy , Controlled Before-After Studies , Feedback , Humans , Japan , Tertiary Care Centers
2.
Yakugaku Zasshi ; 139(2): 317-325, 2019.
Article in Japanese | MEDLINE | ID: mdl-30713244

ABSTRACT

Psychiatric treatment is shifting from hospital to ambulatory care. It is important that pharmacists positively support outpatients. Pharmacist-led interviews with outpatients have been conducted in the psychiatric department of Iizuka Hospital before examination by the doctor since 2015. Few studies in this field have reported about the effect of the pharmacist-led interviews using subjective evaluation of outpatients prior to examination by doctors. The aim of this study was to reveal this effect by the evaluation of outpatients. We conducted a questionnaire survey. More than 80% of the patients responded that it was "Good" to have an interview with the pharmacist prior to examination by the doctor. Moreover, 71.7% of the patients were "Satisfied" with the pharmacist-led interview, while 81.7% of them responded to "Agree" about continuing the interview in the future. Patients who were satisfied and wished to continue the pharmacist-led interviews were more likely to report better rapport with the doctor as well, in comparison to the patients who answered negatively. Furthermore, the patients who answered "Satisfied" were significantly less likely to forget reporting to the doctor than those who answered negatively. The pharmacist-led interviews in the psychiatric department were appreciated by the patients. In conclusion, pharmacists can facilitate communication between patients and doctors through these interviews. These results indicate that the pharmacist-led interview before the doctor examination is a useful effort from the perspective of outpatients.


Subject(s)
Interview, Psychological , Mental Disorders/psychology , Mental Disorders/therapy , Mental Health Services , Outpatients/psychology , Pharmacists , Referral and Consultation , Adult , Aged , Female , Humans , Male , Middle Aged , Negotiating , Patient Care Team , Patient Satisfaction , Physician-Patient Relations , Physicians , Surveys and Questionnaires , Young Adult
3.
Acta Med Okayama ; 61(4): 205-12, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17726509

ABSTRACT

Several epidemiological and clinical studies have indicated that the prevalence of psychiatric disorders is higher in diabetic patients than in the general population. In the present studies, we examined the behavioral changes in streptozotocin-induced diabetic rats, and investigated the effects of physical and psychological stress on the hippocampal BDNF levels and on the serotonin 2A (5-HT(2A)) receptor-mediated wet-dog shake responses. The streptozotocin (60 mg/kg, i.p.)-induced diabetes had no significant effects on the immobility time in the forced swim test or on locomotor activity in the open-field test. Moreover, there was no significant difference in the wet-dog shake responses induced by DOI, a 5-HT(2A) receptor agonist, between nondiabetic and diabetic rats. Five-day exposure to physical (electric footshock) and psychological (non-footshock) stress had no significant effect on the hippocampal BDNF level in diabetic or nondiabetic rats. The 2 types of stress had no significant effect on the DOI-induced wet-dog shake responses in nondiabetic rats. In diabetic rats, the repeated exposure to physical stress markedly increased the DOI-induced wet-dog shake responses, but the repeated exposure to psychological stress had no effect. These results suggest that exposure to physical stress augmented the susceptibility to the wet-dog shake responses to 5-HT(2A) receptor stimulation in streptozotocin-induced diabetic rats.


Subject(s)
Behavior, Animal/physiology , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Experimental/psychology , Receptor, Serotonin, 5-HT2A/physiology , Stress, Psychological/physiopathology , Animals , Diabetes Mellitus, Experimental/complications , Disease Models, Animal , Electric Stimulation , Male , Rats , Rats, Wistar , Streptozocin , Stress, Psychological/complications
4.
Acta Med Okayama ; 61(6): 311-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18183075

ABSTRACT

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hyperglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexamethasone and streptozotocin. ACTH (100 ug/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.) and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats. The wet-dog shake responses induced by (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 5-HT2A receptors under the condition of hyperactivity of the HPA axis.


Subject(s)
Hyperglycemia/physiopathology , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Receptor, Serotonin, 5-HT2A/metabolism , Adrenocorticotropic Hormone/pharmacology , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Dexamethasone/pharmacology , Diabetes Mellitus, Experimental/physiopathology , Glucocorticoids/pharmacology , Hormones/pharmacology , Hypothalamo-Hypophyseal System/drug effects , Male , Pituitary-Adrenal System/drug effects , Rats , Rats, Wistar , Stereotyped Behavior/drug effects , Stereotyped Behavior/physiology , Streptozocin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...